OFFICIAL PUBLICATION OF

by its subsidiary APPco

PSA launches new guide to naloxone supply

Megan Haggan 04/02/2016

sad man in front of graffitied wall: harm minimisation story

A new guide to inform pharmacists about the safe and effective supply of naloxone has been released by the PSA. The comprehensive guide has been produced following the TGA’s decision to broaden the scheduling of naloxone – a life-saving medicine used to for opioid overdose – to include a Schedule 3 listing. This means from

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Transaction fees drive MedAdvisor growth

An 89% gross margin? Wow. That's just staggering considering the lack of service and reliability.

Marion Crowther

Transaction fees drive MedAdvisor growth

Why are other software providers - like Z-software not able to introduce a competing system ? Monopolies breed inefficiency.

Robert Smith

Wholesaling deal needs ‘radical restructure’ in 8CPA

Does the Remote and Isolated Pharmacist Association Australia have a website, or contact information?

D vL

Monopolists a threat to small business

This is a reproduced article form the AJP in 1949 - as stated in the introduction. AJP regularly reproduces articles…

(Mary) Kay Dunkley

PSA launches new guide to naloxone supply

Previous Opioid use quadruples in Australia, but others can't access pain relief

Next Dental health resources for cancer patients

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous Opioid use quadruples in Australia, but others can't access pain relief

Next Dental health resources for cancer patients

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.